You need to login in order to view this content
Redirecting to the source: http://mp.weixin.qq.com/s?__biz=Mzg5NzYyMTE5NA==&mid=2247490069&idx=1&sn=34498856aab01adee1aa02fd9a9bfa13
Weixin Official Accounts Platform TsingRay Technology CEO Ding Yuguo invited to give speech at Chinese Sleep Research Society’s Academic Annual Meeting Original TsingRay Technology TsingRay Technology TsingRay Technology Beijing TsingRay Technology Co., Ltd. TsingRay Technology is a national high-tech enterprise transforming scientific research achievements of Tsinghua University, and a specialized and new SME in Beijing. The company, based on Tsinghua University’s 20 years of technical accumulation, conducts cross-disciplinary research, clinical validation, and product development. The developed medical-grade millimeter-wave radar products are widely used in disease diagnosis, chronic disease management, health monitoring, smart elderly care, and other scenarios. 176 original contents September 14, 2024, 17:55 Beijing On September 6, 2024, the much-anticipated 16th annual scientific meeting of the Chinese Sleep Research Society was grandly held in Wuhan, Hubei Province. This high-end academic forum brought together authoritative experts, clinicians, and representatives from the sleep health industry at home and abroad to discuss the latest advances in sleep science, aiming to enhance the depth and breadth of sleep medicine research in China and promote the prosperous development of sleep medicine and related industries. Conference site Mr. Ding Yuguo, CEO of TsingRay Technology, a leading domestic company in the field of millimeter-wave radar AI medical care, was invited to attend the conference and delivered a speech entitled ‘Non-contact Sleep Monitoring Based on Millimeter-Wave Radar AI Technology.’ In his speech, he stated that TsingRay Technology, by collaborating with leading experts in sleep medicine, conducted real-world studies and clinical validation to build a vertical large model for sleep disorders to achieve the identification and diagnosis of sleep disease-related events. Millimeter-wave radar non-contact monitoring technology and artificial intelligence large models also show great potential in diagnosing and managing sleep-related diseases such as respiratory chronic diseases, mental diseases, and cardiovascular diseases. With the advancement of digital and intelligent technologies, the sleep health field is ushering in unprecedented development opportunities. TsingRay will continue to delve deeply, develop advanced technologies, and launch innovative products to contribute to the improvement of global human sleep and related diseases. Ding Yuguo’s speech site Recently, sleep medicine has been listed as an independent tertiary discipline under internal medicine (secondary discipline), on par with traditional disciplines such as cardiology, respiratory medicine, and critical care medicine. This signifies the formal establishment of sleep medicine as an independent discipline. The growth of emerging disciplines not only depends on the diligent work of professional physician teams but also requires the support of technological innovations from enterprises. Especially AI medical enterprises like TsingRay, through developing innovative sleep monitoring technologies and products, provide continuous momentum for the progress of sleep medicine. Screenshot of the paper title page It is worth mentioning that the academic paper ‘Diagnosis of Obstructive Sleep Apnea by a New Radar Device: A Parallel Controlled Study Evaluating Agreement with Polysomnographic Monitoring’ jointly completed by Dean Yin Shankai’s team from Shanghai Sixth People’s Hospital and TsingRay Technology co-founder, Professor Li Gang’s team from Tsinghua University, was published in the Chinese Journal of Otorhinolaryngology Head and Neck Surgery. The study confirmed that the innovative medical device of millimeter-wave radar developed by TsingRay has a high consistency with the polysomnographic monitoring, the gold standard, in diagnosing obstructive sleep apnea and other sleep breathing disorders, further proving the significant advantages of TsingRay’s millimeter-wave radar non-contact monitoring method. || Previous highlights TsingRay Technology invited to Hangzhou Brain Function Summit Forum to showcase innovative sleep monitoring technology TsingRay Technology participated in grassroots industry meeting to aid in the diffusion of quality medical resources to Guyuan Data for life protection, TsingRay Technology helps Shandong Bohong Health to achieve smart medical and elderly care upgrade New product launch: TsingRay Technology collaborates with industry leaders to compose a new chapter in the field of smart medical and elderly care Good news | TsingRay Technology awarded the title of ‘Specialized and New’ Small and Medium-sized Enterprise in Beijing in 2024 Click image for more Preview tags cannot be clicked Close More Mini Program Ad Search ‘undefined’ web results No more messages No more data Send Message Comment Close Comment Submit More Expressions Scan to Follow Continue sliding to see next Tap to read original text TsingRay Technology Slide up to see next The current content may contain third-party commercial marketing information that has not been reviewed, please confirm whether to continue to access. Continue to access Cancel WeChat Official Account Advertisement Guidelines Got It Scan with WeChat to use this Mini Program Cancel Allow Cancel Allow × Analysis: ， . Video Mini Program Like double tap to cancel like Wow double tap to cancel wow Share Comment Favorite TsingRay Technology TsingRay Technology CEO Ding Yuguo invited to give speech at Chinese Sleep Research Society’s academic annual meeting , Choose a comment identity ‘Ding Yuguo’, ’16th National Academic Annual Meeting’, ‘Chinese Sleep Research Society’, ‘Organizer: Chinese Association’, ‘Organizer Hubei Provincial Representative’, ‘Co-organizer Union Red Cross Hospital (Wuhan Medical Association)’, ‘Tsinghua University School of Medicine Affiliated Hospital’, ‘Hubei · Wuhan 2024 September 6~8’, ‘Ding Yuguo’, ‘WeChat Official Account · TsingRay Technology’, ‘No’, ‘Diagnosis of Obstructive Sleep Apnea by a New Radar Device: A Parallel Controlled Study Evaluating Agreement with Polysomnographic Monitoring’, ‘Li Yang Wang Huang Wei Xu Hua Hong Liang Guan Jian Li and Yin Shangkai’, ‘Authors and Affiliations Information②’, ‘Published: 2024-08-07 – DOI:10.3760/cmsl.cn115330-20231204-00267’, ‘Diagnosis of obstructive sleep apnea by a new radar device: a parallel controlled study evaluating agreement with polysomnographic monitoring’, ‘Authors Information & Affiliations’, ‘Published: 2024-08-07 – DOI: 10.3760/cma.j.cn115330-20231204-00267′, ’55 Shan 260001’, ‘C’, ‘Mouth’, ‘PDF download’, ‘Abstract’, ‘Cite this article’, ‘9’, ‘Objective to evaluate the effectiveness of a new sleep monitoring system QSA600 based on millimeter-wave radar compared with polysomnography (PSG) in diagnosing obstructive sleep apnea’, ‘(obstructive sleep apnea, PERMISSIONS’, ‘Methods from July to September 2023, 155 subjects were recruited to undergo PSG and QSA600 clinical trials at the Sleep Laboratory of the Department of Otorhinolaryngology Head and Neck Surgery, Shanghai Sixth People’s Hospital, 145 subjectsevaluating agreement with polysomnographic monitoring’, ‘eusuenuunxu Guen Du’, ‘Authors Info & Affiliations’, ‘Published: 2024-08-07 – DOI: 10.3760/cma.J.cn115330-20231204-00267′, ’55 Shan 260001’, ‘C’, ‘mouth’, ‘PDF below’, ‘Abstract’, ‘Cite this article’, ‘9’, ‘Objective: To evaluate the new low-burden sleep monitoring system QSA600 based on pen-in-wave reach with polysomnography (PSG) in diagnosing obstructive sleep apnea’, ‘(obstructive sleep apnea, ‘PERMISSIONS’, ‘Methods: From July to September 2023, 155 subjects were recruited and underwent PSG and QSA600 in the Sleep Laboratory of the Otolaryngology Head and Neck Surgery at Jianke General Hospital of Shanghai. 145 subjects were included in the final analysis, including 75 males and 70 females, aged (35.30±12.41) years, height (168.23±8.08) cm, weight (68.28±13.74) kg, conducting a random parallel control study. The apnea-hypopnea index (AHI) was used to divide the subjects into 4 groups: